|
2023
|
Invention
|
Sting levels as a biomarker for cancer immunotherapy.
Provided herein are STING and SPARCS genes... |
|
|
Invention
|
Compounds and methods for treating cancer.
The present application relates to compounds comprisi... |
|
|
G/S
|
Active biochemical ingredients being biological molecules for use in the manufacture of pharmaceu... |
|
|
Invention
|
Engineered bifunctional receptors and uses thereof. Described in several example embodiments here... |
|
|
Invention
|
Novel irisin peptides and methods of use thereof. The present invention provides novel irisin pep... |
|
|
Invention
|
Cyclic nucleotides and uses thereof. The present invention provides novel cyclic nucleotide deriv... |
|
|
Invention
|
Dna barrel nanostructure vaccines. The disclosure relates to nucleic acid-based vaccines for canc... |
|
|
Invention
|
Genetically defined immune-checkpoint inhibitor resistance in aggressive precursors of hpv--head ... |
|
|
Invention
|
Irreversible inactivators targeting araf/mek complexes. The disclosure relates to compounds that ... |
|
|
Invention
|
Personalized muc1-c induced pluripotent stem cell and dendritic cell based vaccines. The present ... |
|
|
Invention
|
Sulfonamide derivatives for protein degradation.
DCAF15 is a substrate recognition (adaptor) pro... |
|
|
Invention
|
Receptor-mediated endocytosis for targeted degradation and delivery of therapeutic agents. Disclo... |
|
|
Invention
|
Receptor-mediated endocytosis for targeted internalization and degradation of membrane proteins a... |
|
|
Invention
|
Methods for treatment selection for chronic lymphocytic leukemia (cll). As described below, the p... |
|
|
Invention
|
Reversible control of chimeric antigen receptor t cells. Disclosed are receptor traps that regula... |
|
|
Invention
|
Panels and methods for treatment of diffuse large b-cell lymphoma.
The invention provides a mole... |
|
|
Invention
|
Compositions and methods for characterizing lymphoma and related conditions.
The invention provi... |
|
|
Invention
|
C-raf mutants that confer resistance to raf inhibitors.
Nucleic acids and proteins having a muta... |
|
|
Invention
|
Mek1 mutation conferring resistance to raf and mek inhibitors.
An isolated nucleic acid molecule... |
|
|
Invention
|
Covalent pparg inverse-agonists.
The present invention includes compounds of formula (I)
The p... |
|
|
Invention
|
Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways.... |
|
|
Invention
|
Antibodies against cldn4 and methods of use thereof. The present invention comprises human antibo... |
|
|
Invention
|
Antibodies against msln and methods of use thereof. The present invention comprises human antibod... |
|
|
Invention
|
Macrocyclic bcl6 degraders. Described are the compounds, compositions and methods of treating dis... |
|
|
Invention
|
1h-pyrrolo[3,2-b]pyridine derivatives as irreversible inhibitors of mutant egfr for the treatment... |
|
|
Invention
|
Compositions and methods for transient gene therapy with enhanced stability.
The present inventi... |
|
|
Invention
|
Generation of anti-tumor t cells.
Disclosed are methods for identifying expanded, exhausted, and... |
|
|
Invention
|
Compositions and methods of treating fanconi anemia.
The present invention provides methods of t... |
|
|
Invention
|
Quinoxalinedione and pyrido [2, 3-b]pyrazine-2, 3-dione b cell lymphoma 6 (bcl6) degraders and us... |
|
|
Invention
|
Compositions and methods for treating cancer with interferon-omega and analogs thereof. The prese... |
|
|
Invention
|
Combination of macrophage-directed immunotherapy and cytokines for treatment of cancer. The prese... |
|
|
Invention
|
Potent and selective irreversible inhibitors of irak1. The disclosure relates to compounds that a... |
|
|
Invention
|
Selective histone deacetylase 3 (hdac3) degraders and methods of use thereof. The present disclos... |
|
|
Invention
|
Selective histone deacetylase 8 (hdac8) degraders and methods of use thereof. The present disclos... |
|
|
Invention
|
Deubiquitinase inhibitors and methods of use thereof. The disclosure relates to compounds that ac... |
|
|
Invention
|
Inhibitors of trim33 and methods of use.
The application relates to a compound of Formula (I):
... |
|
|
Invention
|
Humanized cc chemokine receptor 4 (ccr4) antibodies and methods of use thereof.
The present inve... |
|
|
Invention
|
Compounds for tau protein degradation.
Provided herein are bifunctional compounds that bind tau ... |
|
|
Invention
|
Compositions, assays, and methods for targeting hdm2 and hdmx to reverse the inhibition of p53 in... |
|
|
G/S
|
reagents for scientific or medical research; reagents for diagnostic use; antibodies for use in m... |
|
2022
|
Invention
|
Sars-cov-2 antigen nanoparticles and uses there of.
Provided herein are nanoparticles which enha... |
|
|
Invention
|
Methods of treating red blood cell disorders.
The present invention relates, in part, to methods... |
|
2021
|
Invention
|
Method for duplex sequencing.
The disclosure provides a powerful new approach to dual-strand hig... |
|
|
Invention
|
Personalized fusion cell vaccines.
The present invention provides compositions and methods for t... |
|
|
Invention
|
Antiviral structurally-stabilized ebolavirus peptides and uses thereof.
This disclosure features... |
|
|
Invention
|
Piperidinyl small molecule degraders of helios and methods of use.
Disclosed are compounds and p... |
|
|
Invention
|
Prpk inhibitors.
This disclosure relates to compounds of formula (I) as defined in the Specifica... |
|
|
Invention
|
Inhibitors of transcriptional enhanced associate domain (tead) and uses thereof.
Provided herein... |
|
|
Invention
|
Potent and selective irreversible inhibitors of irak1.
The disclosure relates to compounds that ... |
|
|
Invention
|
Antiviral structurally-stabilized sars-cov-2 peptides and uses thereof.
Disclosed herein are cro... |
|
|
Invention
|
Map kinase kinase (mkk7) inhibitors and uses thereof.
Provided herein are compounds of Formula (... |
|
2020
|
Invention
|
Tricyclic kinase inhibitors and uses thereof.
The present disclosure provides compounds of Formu... |
|
|
G/S
|
Investment services, namely, capital investment services |
|
|
G/S
|
medical research services, medical research services in the field of cancer |
|
|
G/S
|
Charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
|
G/S
|
Charitable fundraising for promotion of public education and
awareness of biomedical sciences re... |
|
|
G/S
|
charitable fundraising for promotion of public education and awareness of biomedical sciences res... |
|
|
G/S
|
Fund-raising services for biomedical sciences research, particularly with regard to the preventio... |
|
|
G/S
|
Fund-raising services for biomedical sciences research,
particularly with regard to the preventi... |
|
2019
|
G/S
|
Medical research in the field of prevention, diagnosis and treatment of cancer and AIDS; medical ... |
|
|
G/S
|
Medical research in the field of prevention, diagnosis and
treatment of cancer and aids; medical... |
|
|
G/S
|
Medical and scientific research services in the field of diagnosis and treatment of cancer and au... |
|
|
G/S
|
Medical and scientific research services; providing
information in the fields of medical and sci... |
|
|
G/S
|
medical and scientific research services; providing information in the fields of medical and scie... |
|
2018
|
G/S
|
providing multiple user access to a platform for providing risk analysis, prediction, treatment, ... |
|
2017
|
G/S
|
charitable fundraising services; charitable fundraising services by means of an ice cream festiva... |
|
|
G/S
|
clinical risk assessment services in the nature of genetic testing for medical purposes based on ... |
|
2014
|
G/S
|
Charitable fundraising services; charitable fundraising services by organizing, sponsoring and co... |
|
2013
|
G/S
|
Charitable fund raising services to raise money for cancer treatment center operations, cancer re... |
|
2012
|
G/S
|
Providing medical and scientific research information in the fields of clinical trials and cancer... |
|
|
G/S
|
Charitable fundraising services, namely, fundraising for promotion of public education and awaren... |
|
2009
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring golf tournaments to raise mon... |
|
2005
|
G/S
|
Charitable fundraising services, namely raising money for cancer treatment center operations, can... |
|
|
G/S
|
Charitable fund raising services, namely, organizing and sponsoring ice cream eating festivals to... |
|
|
G/S
|
Charitable fund raising services, namely, sponsoring co-branded license plates that are sold to r... |
|
2003
|
G/S
|
Reagents for scientific or medical research; Antibodies for use in medical research; [ Diagnostic... |
|
2002
|
G/S
|
MEDICAL RESEARCH IN THE FIELD OF PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER AND AIDS MEDICAL S... |
|
|
G/S
|
Fundraising for promotion of public education and awareness of biomedical sciences research, part... |
|
2000
|
G/S
|
Charitable and memorial fund raising services for biomedical research, particularly with regard t... |
|
1998
|
G/S
|
medical research and services in the field of prevention, diagnosis and treatment of cancer and AIDS |
|
1988
|
G/S
|
FUND-RAISING SERVICES FOR BIOMEDICAL SCIENCES RESEARCH, PARTICULARLY WITH REGARD TO THE PREVENTIO... |
